PB Ratio: 89.50

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 89.50 is 181% above its estimated 5-year average of 31.91, around the middle of its estimated 5-year range (12.24–176.53).

As of 2026-10-06T12:41:53.782Z. 31.74% above its estimated 12-month average of 67.94.

HALO PB Ratio Metrics

P/B vs. estimated history

At 89.50, P/B is above its estimated 20-year median — higher than 92% of readings in its estimated 20-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Halozyme Therapeutics, Inc. (HALO)?

The P/B ratio for HALO stock is 89.50.

Is Halozyme Therapeutics, Inc.'s P/B ratio high or low?

The P/B ratio of 89.50 is 181% above its estimated 5-year average of 31.91, around the middle of its estimated 5-year range (12.24–176.53).

What is the estimated TTM average P/B ratio for Halozyme Therapeutics, Inc. (HALO)?

The estimated TTM average P/B ratio for HALO stock is 67.94.

What is the estimated 3Y average P/B ratio for Halozyme Therapeutics, Inc. (HALO)?

The estimated 3Y average P/B ratio for HALO stock is 27.04.

What is the estimated 5Y average P/B ratio for Halozyme Therapeutics, Inc. (HALO)?

The estimated 5Y average P/B ratio for HALO stock is 31.91.

What is the estimated 10Y average P/B ratio for Halozyme Therapeutics, Inc. (HALO)?

The estimated 10Y average P/B ratio for HALO stock is 31.91.

What is the estimated 15Y average P/B ratio for Halozyme Therapeutics, Inc. (HALO)?

The estimated 15Y average P/B ratio for HALO stock is 32.67.

What is the estimated 20Y average P/B ratio for Halozyme Therapeutics, Inc. (HALO)?

The estimated 20Y average P/B ratio for HALO stock is 28.84.

Showing the most recent 260 of 4,590 data points. The chart above shows the full history.

Related Metrics